The findings are reviewed weekly to ensure that the data collection process is reliable. In addition to charts, medication order sheets and medication administration records (MARs) are reviewed daily.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...

25."A man in his thirties was suddenly at the door. He was crunched over like he was having severe abdominal pain. He was ...

In the gap between rhetoric and action, plenty of space exists for others, including his own advisers, to impose their own ...

The influx of these drugs to our Nation threatens the fabric of our society,” said Mr Trump’s announcement of the levy on Chinese goods. He accused China of “actively sustaining and expanding the ...

A study of efforts to limit or prevent COVID-19 in nursing homes shows that many steps were unproven and gave little or no conclusive help.

Medications: Medications like antidepressants ... the risk of weight-related health problems like obesity and heart disease.

Looking for a reliable way to lose weight?? Meet Mounjaro UAE, the latest injectable medication that’s making waves among adults. This powerful treatment features tirzepatide, which works with your ...

Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these crucial price levels.